Pharma

Key Points: 1. European pharma leaders push for higher drug prices to boost global competitiveness. 2. CEOs warn EU may...

Key Points: 1. Lilly sues four telehealth firms for unauthorized compounding of Mounjaro and Zepbound. 2. GLP 1 drugs remain...

Key Points: 1. FDA approves Dupixent as the first new CSU treatment in over a decade. 2. Phase 3 trial...

Drugmakers Increase Prices on Over 250 Medications Pharmaceutical companies have raised prices on over 250 branded medications in the U.S.,...

1. In this phase 1 randomized controlled trial, urticaria was reported in several participants who received a messenger RNA vaccine...

1. While not statistically significant, the use of sotorasib plus panitumumab may have a 30% relative risk reduction in the...

Ctexli significantly reduced levels of two atypical cholesterol metabolites usually elevated in patients with cerebrotendinous xanthomatosis (CTX) compared to the...

1. In this retrospective cohort study, tirzepatide dispensations were found to have increased significantly following approval in the United States...

1. In this randomized controlled trial, in patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced...

1. In this rapid review, patients valued effectiveness for treating pain more highly than other attributes such as avoiding harm...